SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): January 24, 2011
CHINA SHENGHUO PHARMACEUTICAL HOLDINGS, INC.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
| 001-33537 | 20-2903562 |
| (Commission File Number) | (IRS Employer Identification No.) |
| No. 2, Jing You Road | |
| Kunming National Economy & | |
| Technology Developing District | |
| People’s Republic of China 650217 | N/A |
| (Address of Principal Executive Offices) | (Zip Code) |
0086-871-728-2628
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events.
On January 24, 2011, China Shenghuo Pharmaceutical Holdings, Inc. (the “Company”) issued a press release announcing that “Lixuwang”, the trademark of its best selling product, Xuesaitong Capsule, was awarded the Chinese Well-Known Trademark Honor by the State Administration for Industry and Commerce of China
A copy of the Company’s press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and the information therein is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
Exhibit Number | | Description |
| 99.1 | | Press Release of China Shenghuo Pharmaceutical Holdings, Inc., dated January 24, 2011. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | |
| | CHINA SHENGHUO PHARMACEUTICAL HOLDINGS, INC. |
Date: January 25, 2011 | | |
| | By: | /s/ Gui Hua Lan |
| | | Name: Gui Hua Lan Title: Chief Executive Officer |
EXHIBIT INDEX
Exhibit Number | | Description |
| 99.1 | | Press Release of China Shenghuo Pharmaceutical Holdings, Inc., dated January 24, 2011. |
